On March 6, 2018, John T. Blake, Senior Vice President, Finance and principal financial and accounting officer of aTyr Pharma, Inc. provided his resignation to pursue another opportunity, effective as of the close of business on the date the Company files its Form 10-K for the year ended December 31, 2017, which is currently anticipated to be March 20, 2018.